Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00000434033 · Dead
| Application Number | UK00000434033 |
| Status | Dead |
| Owner | Weleda A.G. |
| Filed | 1923-02-06 |
| Registered | 1923-02-06 |
| Renewal Due | 2007-02-06 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
SCLERON has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
A medicinal preparation for human use in the treatment of arteriosclerosis.
'SCLERON' is a dead trademark on the UK IPO register, owned by Weleda A.G.. The application (UK00000434033) was filed on 6 February 1923 and registered on 6 February 1923. The registration is set to expire on 6 February 2007.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Murgitroyd & Company.
According to the UK IPO register, 'SCLERON' is owned by Weleda A.G..
No — the UK IPO records the status of 'SCLERON' as dead.
'SCLERON' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: A medicinal preparation for human use in the treatment of arteriosclerosis.
The application for 'SCLERON' was filed on 6 February 1923 and the trademark was registered on 6 February 1923.
The UK IPO first published / advertised 'SCLERON' on 12 March 1924.
The current registration of 'SCLERON' is recorded as valid until 6 February 2007, at which point it will need to be renewed to remain in force.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.